Alerts will be sent to your verified email
Verify Email
VINEETLAB
|
Vineet Laboratories
|
Veerhealth Care
|
Kabra Drugs
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
6.26 % | 2.69 % | 65.41 % |
|
5yr average Equity Multiplier
|
3.18 | 1.31 | -11.28 |
|
5yr Average Asset Turnover Ratio
|
1.36 | 0.54 | 0.0 |
|
5yr Avg Net Profit Margin
|
1.11 % | 4.02 % | 0.0 |
|
Price to Book
|
1.0 | 1.08 | 7.92 |
|
P/E
|
0.0 | 0.0 | 0.0 |
|
5yr Avg Cash Conversion Cycle
|
89.15 Days | 80.55 Days | 0.0 |
|
Inventory Days
|
66.38 Days | 54.84 Days | 0.0 |
|
Days Receivable
|
80.91 Days | 79.49 Days | 0.0 |
|
Days Payable
|
81.06 Days | 58.93 Days | 0.0 |
|
5yr Average Interest Coverage Ratio
|
2.14 | 208.32 | -836.53 |
|
5yr Avg ROCE
|
14.46 % | 4.25 % | 64.57 % |
|
5yr Avg Operating Profit Margin
|
3.72 % | 0.98 % | 0.0 |
|
5 yr average Debt to Equity
|
0.69 | 0.06 | -6.16 |
|
5yr CAGR Net Profit
|
n/a | 5.08 % | 65.28 % |
|
5yr Average Return on Assets
|
1.2 % | 2.18 % | -21.32 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
35.85 % | 31.5 % | 0.0 |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
-0.11 % | -10.84 % | 0.0 |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Vineet Laboratories
|
Veerhealth Care
|
Kabra Drugs
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|